Cargando…
ZNF500 abolishes breast cancer proliferation and sensitizes chemotherapy by stabilizing P53 via competing with MDM2
Zinc finger protein 500 (ZNF500) has an unknown expression pattern and biological function in human tissues. Our study revealed that the ZNF500 mRNA and protein levels were higher in breast cancer tissues than those in their normal counterparts. However, ZNF500 expression was negatively correlated w...
Autores principales: | Ma, Xiaowen, Fan, Mingwei, Yang, Kaibo, Wang, Yuanyuan, Hu, Ran, Guan, Mengyao, Hou, Yuekang, Ying, Jiao, Deng, Ning, Li, Qingchang, Jiang, Guiyang, Zhang, Yong, Zhang, Xiupeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637072/ https://www.ncbi.nlm.nih.gov/pubmed/37700392 http://dx.doi.org/10.1111/cas.15947 |
Ejemplares similares
-
ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients
por: Zhang, Xiupeng, et al.
Publicado: (2017) -
Regulation of p53: a collaboration between Mdm2 and MdmX
por: Pei, Dongsheng, et al.
Publicado: (2012) -
The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013) -
MDM4 expression as an indicator of TP53 reactivation by combined targeting of MDM2 and MDM4 in cancer cells without TP53 mutation
por: Hirose, Mitsuaki, et al.
Publicado: (2014) -
Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction
por: Thayer, Kelly M., et al.
Publicado: (2016)